IP Verse

Vertex Pharmaceuticals Incorporated opposition analysis

COMPANY ANALYSIS

Latest patents of Vertex Pharmaceuticals Incorporated opposed by its competitors

Patent:
EP2464337
Grant Date:
Jun 26, 2024
Title:
Pharmaceutical Composition And Administrations Thereof
Oppositions:
1
Patent:
EP2914248
Grant Date:
Oct 18, 2023
Title:
Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases
Oppositions:
1
Patent:
EP3925607
Grant Date:
Jun 28, 2023
Title:
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
Oppositions:
1
Patent:
EP3880197
Grant Date:
Feb 22, 2023
Title:
Methods Of Treatment For Cystic Fibrosis
Oppositions:
2
Patent:
EP3752510
Grant Date:
Dec 7, 2022
Title:
Macrocycles As Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions Thereof, Their Use In The Treatment Of Cycstic Fibrosis, And Process For Making Them
Oppositions:
1
Patent:
EP3798214
Grant Date:
Sep 14, 2022
Title:
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
Oppositions:
1
Patent:
EP3345625
Grant Date:
Dec 9, 2020
Title:
Pharmaceutical Composition And Administrations Thereof
Oppositions:
3
Patent:
EP3203840
Grant Date:
Aug 5, 2020
Title:
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
Oppositions:
1
Patent:
EP3131582
Grant Date:
May 23, 2018
Title:
Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
Oppositions:
1

Competitors of Vertex Pharmaceuticals Incorporated

GENERICS (U.K.) LIMITED

TEVA PHARMACEUTICAL INDUSTRIES LTD.

GENERICS [UK] LIMITED

Want to track Vertex Pharmaceuticals Incorporated?

Feel free to send us a message here and we will get back to you